SYSCHEM (INDIA)
Back to Cashflow Statement
|
SYSCHEM (INDIA) Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹32 Cr | ₹11 Cr | ₹-0.28 Cr | ₹-0.06 Cr | ₹-0.02 Cr |
What is the latest Cash Flow from Financing Activities ratio of SYSCHEM (INDIA) ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹32 Cr |
Mar2023 | ₹11 Cr |
Mar2022 | ₹-0.28 Cr |
Mar2021 | ₹-0.06 Cr |
Mar2020 | ₹-0.02 Cr |
How is Cash Flow from Financing Activities of SYSCHEM (INDIA) Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹32 Cr | 196.01 | |
Mar2023 | ₹11 Cr | Positive | |
Mar2022 | ₹-0.28 Cr | Negative | |
Mar2021 | ₹-0.06 Cr | Negative | |
Mar2020 | ₹-0.02 Cr | - |
Compare Cash Flow from Financing Activities of peers of SYSCHEM (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYSCHEM (INDIA) | ₹178.4 Cr | 2.8% | 12.1% | -35.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹440,314.0 Cr | -0.4% | 5.7% | 20.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,809.0 Cr | 1.7% | 6.2% | 52.9% | Stock Analytics | |
CIPLA | ₹124,627.0 Cr | -0.7% | 7% | 8.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹111,127.0 Cr | -1.6% | 1.5% | 21.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,839.9 Cr | -2.3% | 2.5% | -6% | Stock Analytics |
SYSCHEM (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYSCHEM (INDIA) | 2.8% |
12.1% |
-35.1% |
SENSEX | 2% |
4.1% |
9.6% |
You may also like the below Video Courses